BATS BZX Real-Time Price
As of 10:54am ET
| +0.14 / +0.27%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 66.00 and a low estimate of 39.00. The median estimate represents a -5.25% decrease from the last price of 52.77.
The current consensus among 8 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.